FOLH1 and posterior cortical atrophy: Recently, in an Australian, multi-center, randomized, phase III clinical trial (proPSMA) [70], [68Ga]Ga-PSMA-11 PET provided greater accuracy in identifying nodal and distant metastases vs. conventional imaging (CT and bone scan) prior to curative-intent surgery or radiotherapy in high-risk PCa.